---
title: "HROWL.US (HROWL.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/HROWL.US/news.md"
symbol: "HROWL.US"
name: "HROWL.US"
parent: "https://longbridge.com/en/quote/HROWL.US.md"
datetime: "2026-06-14T03:02:32.656Z"
locales:
  - [en](https://longbridge.com/en/quote/HROWL.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/HROWL.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/HROWL.US/news.md)
---

# HROWL.US (HROWL.US) — Related News

### [Harrow Adds Another Piece To Ophthalmology Strategy](https://longbridge.com/en/news/289489814.md)
*2026-06-11T15:42:29.000Z*
> Harrow Inc. announced the relaunch of VERKAZIA (cyclosporine ophthalmic emulsion) 0.1% for treating vernal keratoconjunc

### [Harrow expects second-quarter revenue of $71 million to $81 million, reiterating its full-year performance guidance](https://longbridge.com/en/news/286147021.md)
*2026-05-12T19:45:32.000Z*
> Harrow Inc. expects second-quarter revenue to be between $71 million and $81 million, and reaffirms its full-year perfor

### [Transcript: Harrow Q1 2026 Earnings Conference Call](https://longbridge.com/en/news/286127404.md)
*2026-05-12T15:29:47.000Z*
> Harrow Inc (NASDAQ:HROW) reported Q1 2026 revenues of $44.2 million, with an adjusted EBITDA of -$12.7 million, impacted

### [](https://longbridge.com/en/news/285994905.md)
*2026-05-11T20:27:52.000Z*
> Harrow shares are trading lower after the company reported worse-than-expected Q1 financial results.

### [April 2026's Top Growth Companies With Strong Insider Ownership](https://longbridge.com/en/news/282578078.md)
*2026-04-13T18:02:59.000Z*
> The U.S. market has risen 3.1% in the past week and 27% over the last year, with earnings expected to grow by 16% annual

### [LogiCare3PL Selected as Distribution Partner by Harrow | HROW Stock News](https://longbridge.com/en/news/282710521.md)
*2026-04-14T06:31:03.000Z*
> LogiCare3PL Selected as Distribution Partner by Harrow | HROW Stock News

### [Harrow Health Expands Senior Notes Offering for Growth](https://longbridge.com/en/news/280845764.md)
*2026-03-27T20:52:50.000Z*
> Harrow Health Expands Senior Notes Offering for Growth

### [Opaleye Trims Harrow Stake After Earnings Miss While Debt Risk Rises](https://longbridge.com/en/news/280832542.md)
*2026-03-27T17:57:18.000Z*
> Opaleye Management sold nearly 200,000 shares of Harrow after a disappointing earnings report, reducing its stake to clo

### [Harrow prices $50M senior unsecured notes due 2030 at 8.625%](https://longbridge.com/en/news/280373227.md)
*2026-03-24T21:21:16.000Z*
> Harrow (Nasdaq: HROW) has priced a private offering of $50 million in senior unsecured notes due 2030 at an interest rat